Minimizing waste during preparation of blinatumomab infusions

Am J Health Syst Pharm. 2016 Jan 15;73(2):19-20. doi: 10.2146/ajhp150420.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific / administration & dosage
  • Antibodies, Bispecific / economics*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / economics*
  • Drug Compounding / economics
  • Drug Compounding / methods
  • Fees, Pharmaceutical*
  • Humans
  • Infusions, Intravenous
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / economics

Substances

  • Antibodies, Bispecific
  • Antineoplastic Agents
  • blinatumomab